Remyelination in MS: Scientists Uncover Promising Treatment Pathway

Remyelination in MS: Scientists Uncover Promising Treatment Pathway Introduction Multiple sclerosis (MS) research has entered a transformative phase with the emergence of two promising therapies aimed at restoring myelin, the protective sheath around nerve fibers that is progressively damaged in MS. Affecting an estimated 2.5 million

Ocrelizumab Effectiveness In Multiple Sclerosis

Ocrelizumab Effectiveness In Multiple Sclerosis Overview Throughout its clinical development program, ocrelizumab has consistently demonstrated efficacy in enhancing clinical outcomes for multiple sclerosis, encompassing annualized relapse rates and confirmed disability progression. Despite these positive findings, the translation of this efficacy into real-world clinical practice remained uncertain. This study aimed to systematically compile

LEAP-MS: Adaptions for Advanced Stages

LEAP-MS: Adaptions for Advanced Stages Lifestyle, Exercise and Activity Package for People Living with Progressive Multiple Sclerosis (LEAP-MS): adaptations for remote delivery & improved efficiency Multiple sclerosis (MS) is the most common neurologic disorder of young and middle-aged adults. MS expresses itself in four clinical forms: relapsing-remitting MS (RRMS), secondary progressive MS

MS: Exercise Impacts on MRI

MS: Exercise Impacts on MRI Multiple sclerosis (MS) is a chronic condition that affects the optic nerves, spinal cord, and brain. Symptoms of MS include body tingling, numbness, weakness, and poor vision. Other uncommon symptoms include cognitive problems, urinary issues, and muscle stiffness.  The problem with most cases of MS is it's

Remyelination in MS: Scientists Uncover Promising Treatment Pathway